| 发明名称 |
RETROGRADE DELIVERY OF SDF-1 FOR TREATMENT OF MYOCARDIAL INFARCTION |
| 摘要 |
Described herein are methods of treating a subject with a cardiomyopathy by administering to the subject's heart, via percutaneous retrograde coronary sinus perfusion, a pharmaceutical composition that comprises a DNA plasmid encoding SDF-1 and a pharmaceutically acceptable carrier or diluent. |
| 申请公布号 |
US2016024521(A1) |
申请公布日期 |
2016.01.28 |
| 申请号 |
US201414773984 |
申请日期 |
2014.03.15 |
| 申请人 |
THE CLEVELAND CLINIC FOUNDATION ;JUVENTAS THERAPEUTICS, INC. |
发明人 |
PENN Marc S.;ARAS Rahul;PASTORE Joseph;FISHER Scott J. |
| 分类号 |
C12N15/85;A61M25/10 |
主分类号 |
C12N15/85 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a subject with an ischemic cardiomyopathy comprising administering to the subject's heart, via percutaneous retrograde coronary sinus perfusion, a pharmaceutical composition that comprises a DNA plasmid encoding SDF-1 and a pharmaceutically acceptable carrier or diluent. |
| 地址 |
Cleveland, OH US |
